Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial-Reference-Cited by-同舟云学术

Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial

Published:2021-07 Issue: Volume: Page:
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Mehra Mandeep R.¹,Crandall Daniel L.²,Gustafsson Finn³,Jorde Ulrich P.⁴,Katz Jason N.⁵,Netuka Ivan⁶,Uriel Nir⁷,Connors Jean M.⁸,Sood Poornima²,Heatley Gerald⁹,Pagani Francis D.¹⁰

Affiliation:

1. Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA

2. Clinical Affairs Heart Failure, Abbott Chicago IL USA

3. Cardiology, Rigshospitalet Copenhagen Denmark

4. Einstein Center for Heart and Vascular Care, Montefiore Medical Center Bronx NY USA

5. Division of Cardiology Duke University Durham NC USA

6. Department of Cardiovascular Surgery, IKEM Prague Czech Republic

7. Heart Failure, Heart Transplant & Mechanical Circulatory Support, Columbia University Medical Center New York NY USA

8. Division of Hematology Brigham and Women's Hospital Boston MA USA

9. Global Biometrics, Abbott Chicago IL USA

10. Department of Cardiac Surgery University of Michigan Ann Arbor MI USA

Funder